Extrait

Determine the rate of progression free survival (PFS) at 16 weeks.

Critère d'inclusion

• Approx. 8-11% of all women will develop breast cancer in their lives. Nearly half of the women who develop breast cancer also develop metastatic disease. The average survival time from diagnosis to recurrence for these patients ranges from approx. 18-30 months, the 5-year survival rate is only 21%. HER2 overexpression (usually correlated with aggressive disease and decreased survival) occurs early in the pathogenesis of breast cancer in approx. 15% to 25% of patients with metastatic disease

Liens

• ictrp
• euctr